Virulence-associated enzymes of Cryptococcus neoformans

F Almeida, JM Wolf, A Casadevall - Eukaryotic cell, 2015 - Am Soc Microbiol
Enzymes play key roles in fungal pathogenesis. Manipulation of enzyme expression or
activity can significantly alter the infection process, and enzyme expression profiles can be a …

Advances in combating fungal diseases: vaccines on the threshold

JE Cutler, GS Deepe Jr, BS Klein - Nature Reviews Microbiology, 2007 - nature.com
The dramatic increase in fungal diseases in recent years can be attributed to the increased
aggressiveness of medical therapy and other human activities. Immunosuppressed patients …

Chitosan, the Deacetylated Form of Chitin, Is Necessary for Cell Wall Integrity in Cryptococcus neoformans

LG Baker, CA Specht, MJ Donlin, JK Lodge - Eukaryotic cell, 2007 - Am Soc Microbiol
Cryptococcus neoformans is an opportunistic fungal pathogen that causes cryptococcal
meningoencephalitis, particularly in immunocompromised patients. The fungal cell wall is an …

MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans

C Biondo, A Midiri, L Messina… - European journal of …, 2005 - Wiley Online Library
We investigated here the potential role of Toll‐like receptors (TLR) and the adaptor protein
MyD88 in innate immunity responses to Cryptococcus neoformans, a pathogenic …

Cryptococcus neoformans Cda1 and its chitin deacetylase activity are required for fungal pathogenesis

R Upadhya, LG Baker, WC Lam, CA Specht, MJ Donlin… - MBio, 2018 - Am Soc Microbiol
Chitin is an essential component of the cell wall of Cryptococcus neoformans conferring
structural rigidity and integrity under diverse environmental conditions. Chitin deacetylase …

Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and …

CA Specht, CK Lee, H Huang, MM Hester, J Liu… - MBio, 2017 - Am Soc Microbiol
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …

Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts

CA Specht, CK Lee, H Huang, DJ Tipper, ZT Shen… - MBio, 2015 - Am Soc Microbiol
ABSTRACT A vaccine capable of protecting at-risk persons against infections due to
Cryptococcus neoformans and Cryptococcus gattii could reduce the substantial global …

A call to arms: quest for a cryptococcal vaccine

MCC Van Dyke, FL Wormley - Trends in microbiology, 2018 - cell.com
Cryptococcosis remains a significant cause of morbidity and mortality world-wide,
particularly among AIDS patients. Yet, to date, there are no licensed vaccines clinically …

Iron‐regulated transcription and capsule formation in the fungal pathogen Cryptococcus neoformans

T Lian, MI Simmer, CA D'Souza, BR Steen… - Molecular …, 2005 - Wiley Online Library
Cryptococcus neoformans is the leading cause of fungal meningitis in humans. Production
of a polysaccharide capsule is a key virulence property for the fungus and capsule synthesis …

Vaccines and protective immune memory against cryptococcosis

K Ueno, N Yanagihara, K Shimizu… - Biological and …, 2020 - jstage.jst.go.jp
Cryptococcosis is a potentially lethal disease caused by fungal pathogens including
Cryptococcus neoformans and Cryptococcus gattii species complex. These fungal …